Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
Interleukin 1, a potential regulator of fibroblast proliferation.
1982 • 835 citations
Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2
1984 • 687 citations
Human natural killer cells: biologic and pathologic aspects.
1984 • 419 citations
Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.
1984 • 371 citations
Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.
1981 • 317 citations
Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
1984 • 299 citations
A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous Melanoma
1982 • 282 citations
Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins
1977 • 217 citations
Human large granular lymphocytes are potent producers of interleukin-1
1984 • 212 citations
The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
1984 • 156 citations
Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.
1983 • 123 citations
T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.
1981 • 118 citations
Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells
1984 • 116 citations
Lymphokines: their role in lymphocyte responses. Properties of interleukin 1.
1982 • 113 citations
Primary but not metastatic human melanomas expressing dr antigens stimulate autologous lymphocytes
1984 • 104 citations
HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes.
1984 • 96 citations
Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation.
1982 • 96 citations
Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens.
1981 • 94 citations
Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma.
1984 • 93 citations
Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells
1978 • 92 citations
Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
1982 • 85 citations
Depressed Levels of Granular Lymphocytes with Natural Killer (NK) Cell Function in 247 Cancer Patients
1983 • 76 citations
Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations
1984 • 69 citations
Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture
1983 • 63 citations
Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression.
1982 • 62 citations
The Potential role of T cells in cancer therapy
1982 • 60 citations
Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course
1983 • 55 citations
A Randomized Trial of Levamisole versus Placebo as Adjuvant Therapy in Malignant Melanoma
1980 • 54 citations
Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
1980 • 52 citations
T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients.
1980 • 50 citations
Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course
1983 • 46 citations
Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population.
1982 • 38 citations
Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes
1982 • 34 citations
Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma
1985 • 22 citations
Alloreactivity and Tumor Antigens: Generation of Syngeneic Antilymphoma Killer Lymphocytes by Alloimmunization of Mice With Normal Cells<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>
1983 • 20 citations
Passive adoptive immunotherapy of low‐immunogenic BALB/C lymphoma by syngeneic alloimmune T lymphocytes
1984 • 17 citations
Influence of human interferon-? therapy on cytotoxic functions of blood lymphocytes
1983 • 15 citations
Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes
1983 • 11 citations
Inhibition of Human Melanoma Growth in Nude Mice by Autologous, Alloactivated Peripheral Blood Lymphocytes
1984 • 11 citations
Perusing the ASCO abstracts with a focus on interferons in malignant melanoma and renal cell carcinoma
1984 • 5 citations
Interferon production and tumor cell killing by human lymphocytes stimulated in mixed-lymphocyte culture
1984 • 4 citations
Cited By (0)
No citing papers found in database